Nurix Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $32M | 2.2M | 14.70 |
| 2023-12-31 | $25M | 2.4M | 10.32 |
| 2023-09-30 | $19M | 2.4M | 7.86 |
| 2023-06-30 | $24M | 2.4M | 9.99 |
| 2023-03-31 | $23M | 2.6M | 8.88 |
| 2022-12-31 | $36M | 3.3M | 10.98 |
| 2022-03-31 | $67M | 4.8M | 14.01 |
| 2021-12-31 | $141M | 4.9M | 28.95 |
| 2021-09-30 | $141M | 4.7M | 29.96 |
| 2021-06-30 | $108M | 4.1M | 26.53 |
| 2021-03-31 | $96M | 3.1M | 31.09 |
| 2020-12-31 | $20M | 592k | 32.88 |
| 2020-09-30 | $20M | 563k | 34.91 |